Thromboxane A2 exacerbates acute lung injury via promoting edema formation

Sci Rep. 2016 Aug 26:6:32109. doi: 10.1038/srep32109.

Abstract

Thromboxane A2 (TXA2) is produced in the lungs of patients suffering from acute lung injury (ALI). We assessed its contribution in disease progression using three different ALI mouse models. The administration of hydrochloric acid (HCl) or oleic acid (OA)+ lipopolysaccharide (LPS) caused tissue edema and neutrophil infiltration with TXA2 production in the lungs of the experimental mice. The administration of LPS induced only neutrophil accumulation without TXA2 production. Pretreatment with T prostanoid receptor (TP) antagonist attenuated the tissue edema but not neutrophil infiltration in these models. Intravital imaging and immunostaining demonstrated that administration of TP agonist caused vascular hyper-permeability by disrupting the endothelial barrier formation in the mouse ear. In vitro experiments showed that TP-stimulation disrupted the endothelial adherens junction, and it was inhibited by Ca(2+) channel blockade or Rho kinase inhibition. Thus endogenous TXA2 exacerbates ALI, and its blockade attenuates it by modulating the extent of lung edema. This can be explained by the endothelial hyper-permeability caused by the activation of TXA2-TP axis, via Ca(2+)- and Rho kinase-dependent signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / metabolism*
  • Acute Lung Injury / pathology
  • Animals
  • Hydrochloric Acid / toxicity
  • Lipopolysaccharides / toxicity
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neutrophil Infiltration / drug effects
  • Neutrophils / metabolism
  • Neutrophils / pathology
  • Oleic Acid / toxicity
  • Pulmonary Edema / chemically induced
  • Pulmonary Edema / metabolism*
  • Pulmonary Edema / pathology
  • Thromboxane A2 / metabolism*

Substances

  • Lipopolysaccharides
  • Oleic Acid
  • Thromboxane A2
  • Hydrochloric Acid